Detecting early-warning signals of type 1 diabetes and its leading biomolecular networks by dynamical network biomarkers

BackgroundType 1 diabetes (T1D) is a complex disease and harmful to human health, and most of the existing biomarkers are mainly to measure the disease phenotype after the disease onset (or drastic deterioration). Until now, there is no effective biomarker which can predict the upcoming disease (or pre-disease state) before disease onset or disease deterioration. Further, the detail molecular mechanism for such deterioration of the disease, e.g., driver genes or causal network of the disease, is still unclear.MethodsIn this study, we detected early-warning signals of T1D and its leading biomolecular networks based on serial gene expression profiles of NOD (non-obese diabetic) mice by identifying a new type of biomarker, i.e., dynamical network biomarker (DNB) which forms a specific module for marking the time period just before the drastic deterioration of T1D.ResultsTwo dynamical network biomarkers were obtained to signal the emergence of two critical deteriorations for the disease, and could be used to predict the upcoming sudden changes during the disease progression. We found that the two critical transitions led to peri-insulitis and hyperglycemia in NOD mices, which are consistent with other independent experimental results from literature.ConclusionsThe identified dynamical network biomarkers can be used to detect the early-warning signals of T1D and predict upcoming disease onset before the drastic deterioration. In addition, we also demonstrated that the leading biomolecular networks are causally related to the initiation and progression of T1D, and provided the biological insight into the molecular mechanism of T1D. Experimental data from literature and functional analysis on DNBs validated the computational results.

[1]  I. Chang,et al.  Death effectors of beta-cell apoptosis in type 1 diabetes. , 2004, Molecular genetics and metabolism.

[2]  Xiang-Sun Zhang,et al.  APG: an Active Protein-Gene Network Model to Quantify Regulatory Signals in Complex Biological Systems , 2013, Scientific Reports.

[3]  H. Kikutani,et al.  The murine autoimmune diabetes model: NOD and related strains. , 1992, Advances in immunology.

[4]  C. Benoist,et al.  Initiation of Autoimmune Diabetes by Developmentally Regulated Presentation of Islet Cell Antigens in the Pancreatic Lymph Nodes , 1999, The Journal of experimental medicine.

[5]  Kazuyuki Aihara,et al.  Identifying critical transitions and their leading biomolecular networks in complex diseases , 2012, Scientific Reports.

[6]  Yan Zhang,et al.  Research and applications: An integrated approach to identify causal network modules of complex diseases with application to colorectal cancer , 2013, J. Am. Medical Informatics Assoc..

[7]  N. Rose,et al.  Type 1 diabetes: virus infection or autoimmune disease? , 2002, Nature Immunology.

[8]  Luonan Chen,et al.  Coexpression network analysis in chronic hepatitis B and C hepatic lesions reveals distinct patterns of disease progression to hepatocellular carcinoma. , 2012, Journal of molecular cell biology.

[9]  I. Chang,et al.  Death effectors of β-cell apoptosis in type 1 diabetes , 2004 .

[10]  F. Lepault,et al.  Pancreatic Lymph Nodes Are Required for Priming of β Cell Reactive T Cells in NOD Mice , 2002, The Journal of experimental medicine.

[11]  M. Atkinson,et al.  The NOD mouse model of type 1 diabetes: As good as it gets? , 1999, Nature Medicine.

[12]  Kazuyuki Aihara,et al.  Detecting early-warning signals for sudden deterioration of complex diseases by dynamical network biomarkers , 2012, Scientific Reports.

[13]  Stephen T. C. Wong,et al.  Cross-platform method for identifying candidate network biomarkers for prostate cancer. , 2009, IET systems biology.

[14]  Mark S. Anderson,et al.  The NOD mouse: a model of immune dysregulation. , 2005, Annual review of immunology.

[15]  Bhagirath Singh,et al.  The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. , 1997, Immunity.

[16]  Xing-Ming Zhao,et al.  Identifying disease genes and module biomarkers by differential interactions , 2012, J. Am. Medical Informatics Assoc..

[17]  S. Pervaiz,et al.  Apoptosis in the pathophysiology of diabetes mellitus. , 2007, The international journal of biochemistry & cell biology.

[18]  Atul J Butte,et al.  Tissue- and age-specific changes in gene expression during disease induction and progression in NOD mice. , 2008, Clinical immunology.

[19]  Zhiping Liu,et al.  Network-based analysis of complex diseases. , 2012, IET systems biology.

[20]  Luonan Chen,et al.  Whole-exome sequencing reveals recurrent somatic mutation networks in cancer. , 2013, Cancer letters.

[21]  R. Tisch,et al.  Elevated NF-κB Activation in Nonobese Diabetic Mouse Dendritic Cells Results in Enhanced APC Function1 , 2002, The Journal of Immunology.

[22]  Wen-Chi Chou,et al.  An integrated transcriptomic and computational analysis for biomarker identification in gastric cancer , 2010, Nucleic acids research.

[23]  Luonan Chen,et al.  Identification of dysfunctional modules and disease genes in congenital heart disease by a network-based approach , 2011, BMC Genomics.

[24]  R. Flavell,et al.  Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals. , 2002, Immunity.

[25]  J. Piganelli,et al.  Oxidative Stress and Redox Modulation Potential in Type 1 Diabetes , 2011, Clinical & developmental immunology.